CVS Health Corp's stock rose 5.1% to $95.15, despite GuruFocus assessing it as 22.6% overvalued. The GF Score of 81/100 suggests underlying strength but highlights valuation risks.
CVS Health Stock Rises 5.1% Amid Overvaluation Concerns
CVSstock-performancevaluationhealthcare-sector

